Stephen Pandol to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Stephen Pandol has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
1.216
-
A Randomized, Double-Blinded, Placebo-Controlled Trial of Simvastatin to Prevent Recurrent Pancreatitis. Pancreas. 2022 01 01; 51(1):e10-e12.
Score: 0.711
-
Idiopathic chronic pancreatitis: Beyond antioxidants. World J Gastroenterol. 2021 Nov 21; 27(43):7423-7432.
Score: 0.176
-
Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer. Am J Gastroenterol. 2015 Aug; 110(8):1233-9.
Score: 0.114
-
The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis. PLoS One. 2015; 10(4):e0121783.
Score: 0.111
-
Simvastatin is associated with reduced risk of acute pancreatitis: findings from a regional integrated healthcare system. Gut. 2015 Jan; 64(1):133-8.
Score: 0.104